WASHINGTON, Sept 21 (Reuters) - U.S. lawmakers on Wednesday
blasted Mylan NV Chief Executive Heather Bresch for
sharply increasing prices for the EpiPen emergency allergy
treatment at a congressional hearing in which Republicans and
Democrats questioned the reasons behind rising U.S. drug costs.
Read more
No comments:
Post a Comment